PD-L1 is actively expressed on both tumor cells and antigen-presenting cells, and inhibition of PD-1 potentially affects multiple steps in the early stage of the lymph node and subsequent immune response in the tumor microenvironment [94]. This evidence concerns the gene PDCD1 and neoplasm.